Share on LinkedInShare on LinkedIn

ARTICLE · 15 MARCH 2017

One Is Not Enough – Infringement Liability Under § 271(F)(1)

The Court's decision is important for manufacturers of kit components and those that license and aggregate those components into a single commercial kit.

United StatesIntellectual Property

In Life Technologies Corp. v. Promega Corp., Slip Op. 14-1538 (Feb. 22, 2017), the U.S. Supreme Court held that the supply of a single component of a multicomponent invention for manufacture abroad does not give rise to liability under 35 U.S.C. § 271(f)(1). The Court's decision is important for manufacturers of kit components and those that license and aggregate those components into a single commercial kit.

The Licensed Technology

Respondent Promega Corp. (Promega) was the exclusive licensee of U.S. Re. No. 37,984 titled "Process for analyzing length polymorphisms in DNA regions" and referred to by the Court as the "Tautz patent." The reissued patent covers kits and methods, one element of which is the Taq polymerase enzyme. For the purpose of the litigation, the parties agreed "that the kit covered by the Tautz patent contains five components: (1) a mixture of primers that mark the part of the DNA strand to be copied; (2) nucleotides for forming replicated

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from